Sino Biopharmaceutical | 1177 - Net Income

Stock Price
5.28
Daily Change
-0.02 -0.38%
Monthly
-11.26%
Yearly
26.32%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY3.39B in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025